Microbial colonisation of chronic venous ulcers and synergism between bacterial species slow down the healing process. The study aimed at performing qualitative analysis of microbial flora in venous leg ulcers treated with platelet rich plasma (PRP). Twenty two women and twelve men aged 47-90 years were treated with PRP at our department between 2012 and 2015. Ulcer cultures collected before and after PRP therapy yielded 83 and 110 microbial isolates, respectively, of Gram positive, Gram negative bacteria and candida. Pseudomonas aueruginosa and Staphylococcus aureus were the most common pre and posttreatment isolates. PRP therapy and increased the variety of microbial flora.
Chronic venous leg ulcers ( Fig. 1 ) are a significant diagnostic and therapeutic challenge. In most patients, venous ulcer develops secondarily to chronic venous insufficiency. The recurrent infection affects up to 72% of cases, and after skin graft the annual relapse rate can be as high as 48% (Morimoto et al., 2014) . Chronic nature of venous ulcer, tissue damage, wound exudate and the decreased partial oxygen pressure promote colo nisation and uncontrolled microbial growth. Whereas the colonisation itself does not significantly alter healing process, except for the cases of host immune response, the increase in bacterial count and synergistic inter action between the individual species may hinder ulcer healing, leading to further tissue damage (Bowler, 2002) .
Antimicrobial treatment is difficult and often insuf ficient as antibiotics have poor penetration to the infec tion site (Alinovi et al., 1986) . Therefore the treatment includes improvement of blood flow to the affected site and other types of experimental therapies (Howard et al., 2008; Rosales et al., 2010) . One of the therapeu tic alternatives in refractory venous leg ulcers is platelet rich plasma (PRP) successfully used in orthopaedics, rheumatology, maxillofacial surgery or aesthetic medi cine. PRP is a rich source of autologous growth factors, which participate in coagulation, immune response, angiogenesis and wound healing . There are reports of improved ulcer healing after PRP therapy in comparison with the controls, as well as converse observations (Saad Setta et al., 2011; MartinezZapata et al., 2012) . During our initial clinical attempts to treat venous leg ulcers with PRP, the more severe sings of microbial growth (increased inflamma tory exudate, more intense smell of decomposition) were observed, hence the decision to address this issue. Therefore, we conducted a qualitative analysis of bac terial flora in venous leg ulcers during local treatment with platelet rich plasma.
Between 2012 and 2015, 34 patients with venous leg ulcers were treated at the First Department of Gene ral and Vascular Surgery, Second Faculty of Medicine with the English Division and the Physiotherapy Divi sion, Medical University of Warsaw. The inclusion criteria for the treatment involved completed causal treatment, i.e. the absence of superficial and perfora tor vein reflux as well as the restored iliac vein patency. The exclusion criteria included leg ulcers secondary to atherosclerosisrelated ischaemia, diabetes, rheuma toid arthritis, lymphatic obstruction or phlebitis. The essential eligibility criterion for local treatment with platelet rich plasma was the lack of progress of spon taneous ulcer healing despite completed causal treat ment. The allowed time window was 6 months, i.e. if the ulcer has not resolved or has not presented signs of progressing reepithelialisation within this period, it was eligible for PRP therapy. The culture specimens from the ulcer surface were collected 7-14 days prior to treatment. The specimens were collected using collec tion and transport system swabs and tubes with Amies BO91 medium (ZTS Hagmed). The collected biological material was cultured on the growth media for aero bic bacteria, anaerobic bacteria and fungi using the streak plate method on Columbia Agar with 5% Sheep Blood, Haemophilus agar, MacConkey agar, Chapman agar, Scheadler agar, Sabouraud Dextrose agar, as well as MRSA and Strep B chromogenic media. Antibiotic susceptibility of each bacterial and fungal isolate was determined using either automated method (Vitek 2 Compact, BioMerieux) or Kirby Bauer disk diffusion method. The MIC gradient strips (Etest, The bacte rial colony count was not determined, but only roughly estimated based on the number of colonies grown after plating and noted for diagnostic purposes as: 1 -scanty, 2 -few, 3 -moderate, 4 -numerous.
Platelet rich plasma was prepared from 18-27 ml of blood drawn with syringe from the superficial veins on the forearm. The blood was then transferred to ster ile 9 ml test tubes containing sodium citrate (Vacuette 9NC, Greiner BioOne GmbH, Austria). After mixing, the tubes were left on the tube rack until the RBCs sepa rated from the plasma. The process typically lasted for 3-4 hours. Afterwards, using the new syringe and ven flon cannula (Vasofix Certo 16G 2" B. Braun Melsun gen, Germany) the supernatant (plasma) was collected. The collected plasma was transferred to sterile 9 ml test tubes (Vacuette Z Greiner BioOne GmbH, Austria). The test tubes containing plasma were centrifuged for 15 minutes at 3000 rpm (Low Speed Centrifuge 802C, Pioway Medical Lab Equipment Co., Ltd., China). After centrifuging, using the new syringe and venflon cannula (Vasofix Certo 16G 2" B. Braun Melsungen, Germany) the upper half content of the test tube was collected (4.5 ml). The remaining part of plasma was mixed (VortexGenie 2 Scientific Industries INC, USA) for 30 seconds in order to obtain homogeneous platelet solution. 0.5 ml of the obtained solution was collected for platelet count (Cell Dyn 1700 Abbott Diagnostics, USA). The assay was compared to the automated full blood count results. Platelet concentration ratio ranged from 2.2 to 4.1. Next, 0.1 ml of calcium chloride (10% Calcium chloratum, WZF) was added to each test tube of prepared platelet rich plasma solution. The platelet preparation was administered to the ulcer margins as an intradermal injection, using the 1 ml syringes with 30 G needle (0.3 × -4 mm). Additionally, mesotherapy was performed on ulcer surface and after that, the ulcer was covered with platelet rich plasma. After plasma aggluti nation on ulcer surface, the entire area was covered with a proper size sterile hydrogel wound dressing AquaGel (Kikgel). Wound dressing was changed every 3 days so as to avoid removing the plasma from ulcer surface. Control cultures were collected 3 weeks after the PRP treatment. During that period no antibiotics -local or systemic -were administered. Treatment efficacy was assessed visually based on the ulcer size decrease and the reepithelialisation.
The study group (34 subjects) consisted of 22 women (64.7%) and 12 men (35.3%) whose age ranged from 47 to 90 years. The mean age was 70.5 years (SD 9.8). The surface area of the ulcer ranged from 3 to 92 cm 2 with the mean surface area of 31.94 cm 2 . Single ulcer was present in 25 (73.5%) patients. Double ulcer was shown in 4 (11.8%) patients, whereas 5 subjects (14.7%) presented with multiple ulcers (3 or more). Symptom duration ranged between 11 and 192 months, with the mean duration of 55.8 months.
After PRP therapy, a significant healing improve ment was shown in 21 subjects (61.8%), as assessed by decrease in wound size, whereas in 13 remaining cases (38.2%) there was no improvement.
Microbiological analysis of bacterial flora a in the wounds prior the treatment yielded 83 microbial iso lates. The most commonly isolated bacterial species included (in the order of frequency): Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faeca lis and Bacteroides fragilis. Table I shows quantitative distribution of isolated bacterial and fungal species among patients. The majority of cultures from single swab from the patient (73.5%) showed the presence of multiple species.
Grampositive bacteria were isolated from over 30% of patients, Gramnegative bacteria were isolated from 59% of patients, with anaerobic bacteria and fungi mak ing up 9.6% and 1.2%, respectively. The most commonly isolated Grampositive bacteria were S. aureus, E. faeca lis, and βhemolytic streptococci (Table I) . Ana lysis of antibiotic resistance revealed that among studied iso lates, MRSA strains (Table I ) and enterococci show ing HLAR to gentamicin (3 isolates) were present. No vancomycin resistant enterococci (VRE) were isolated.
The most commonly isolated Gramnegative bacte ria were nonfermenting bacilli, predominantly P. aeru ginosa, Acinetobacter baumanii and Stenotrophomonas maltophilia. Enterobacteriaceae constituted large group of Gram negative bacteria isolated from ulcers. The most commonly isolated species were Serratia marc escens, Morganella morganii, Escherichia coli, Proteus mirabilis, Klebsiella oxytoca and Enterobacter cloacae.
No ESBL(+) Enterobacteriaceae strains were isolated. Two isolates of P. aeruginosa strains showed resistance to impenem and meropenem. B. fragilis was the most commonly isolated anaerobic bacterial species. Candida parapsilosis was isolated in one case.
After PRP therapy, a total of 110 bacterial isolates were obtained from samples collected after a single, local application of platelet rich plasma. Multiple iso lates were cultured for 32 of 34 subjects.
The bacterial species isolated after the treatment were very similar to those isolated previously, however the frequency of MSSA, P. aeruginosa or E. coli isolation increased (Table I ). There were no significant changes 
Morganella morganii 4 7
Escherichia coli 3 10
Proteus mirabilis 3 6
Klebsiella oxytoca 3 4
Enterobacter cloacae 3 5
Pantoea agglomerans 2 1
Proteus vulgaris 1 1
Klebsiella pneumoniae 1 1
Aeromonas hydrophila 0 2
Hafnia alvei 0 1
Gramnegative nonfermenting bacilli Pseudomonas aeruginosa 18 24
Acinetobacter baumannii 2 2
Stenotrophomonas maltophila 2 2
Pseudomonas putida 1 0
Acinetobacter haemolyticus 1 0
Alcaligenes faecalis 1 0
Anaerobic bacteria Bacteroides fragilis 6 6
Bacteroides ovatus 0 1
Prevotella oralis 2 0
Prevotella denticola 0 1
Fungi

Candida parapsilosis 1 0
Candida albicans 0 1 in antibiotic resistance profiles of isolated bacteria. Simi larly to the initial cultures, no vancomycin resistant enterococci were isolated. In this group of isolates, 5,1% strains were classified as ESBL positive and 8,3% of P. aeruginosa strains were resistant to impenem and meropenem. As previously, B. fragilis was the most commonly isolated anaerobic species. Candida albicans was isolated in a single case.
A comparison of the number of isolates in ulcer culture samples before and after PRP therapy showed an increase in the number of isolates containing mul tiple bacterial species. The maximum number of spe cies in a single ulcer was five prior to PRP, it increased up to seven afterwards. The mean number of bacte rial species isolated per subject before and after PRP was 2.44 +/-0.22 and 3.24 +/-0.29, respectively. Paired Ttest comparing group of patients prior and after treat ment shown that the increase in mean number of spe cies is statistically significant (P = 0.035).
A comparison of the most commonly isolated bac teria in culture samples before and after PRP therapy showed a marked increase in the isolation ratio of MSSA and E. coli, with changes in the ratio of other strains being less pronounced (Table I) . Although quan titative analysis was not performed, visual estimation of the colony density on plates with plated bacteria after PRP therapy shows that the use of platelet rich plasma decreased the amount of bacteria in about half of the patients. However, based only on semiquantitative inspection, we cannot speculate if the observed decrease in number of bacteria was statistically significant.
The influence of platelets on wound healing is well known. Chronic ulcers show decreased activity of growth factors, which delays tissue repair mecha nisms. In 1974, Ross et al. found in their in vitro studies that thrombin activated platelets may constitute a rich source of growth factors. Thrombocytes release over 30 growth factors to the wound. These include three isomers of platelet derived growth factor -PDGF (αα, ββ, αβ), vascular endothelial growth factor -VEGF, transforming growth factor β -TGFβ1, epithelial growth factor -EGF, insulinlike growth factor -IGF1, angiopoietin 2 (Ang2), interleukin 1β (IL1β) and many others. Platelet rich plasma is also a source of pro teins involved in cell adhesion, such as fibrin, fibronec tin, vitronectin, osteocalcin or osteonectin (Everts et al., 2006) . The growth factors are released as a result of degranulation of thrombocyte granules soon after the coagulation cascade is initiated and bind the membrane receptors of adjacent cells, thus activating the intracel lular signalling pathway (Anitua et al., 2004; Eppley et al., 2004) . The growth factors attract the undifferenti ated cells within the wound, stimulate cell division, trig ger the capillary growth and improve epithelial repair mechanisms. Additionally, they inhibit cytokine expres sion, thus limiting the inflammatory response (Carter et al., 2011; Scimeca et al., 2010) . Platelet rich plasma shows antibacterial properties, mainly due to PDGF, which activates macrophages and VEGF, which acti vates macrophages and monocytes. Furthermore, PRP contains leukocytes, which enhance its antibacterial properties. In vitro studies showed good efficacy of PRP against S. aureus (MSSA), which was comparable to the one of gentamycin and oxacillin (CieślikBielecka et al., 2012) . Li et al. (2013) observed a significant antibacte rial activity of PRP against MRSA in experimentally induced osteitis in rats. Also Moojen et al. (2008) con firmed the efficacy of PRP against S. aureus. Bielecki et al. (2007) who studied the in vitro effect of platelet rich plasma provided a broad analysis of antibacterial properties of PRP. They assessed the antibacterial effect of PRP by measuring the inhibition zones on agar plates with individual microbial strains. PRP was shown to inhibit the growth of S. aureus, both MSSA and MRSA, as well as E. coli. The effect of PRP on K. pneumoniae, E. faecalis and P. aeruginosa was not confirmed. In the case of P. aeruginosa, PRP may even induce micro bial growth (ref) . Chronic ulcers are typically colo nised by S. aureus and P. aeruginosa (Lim et al., 2006) . As postulated by Gjodsbol et al. (2006) , the presence of P. aeruginosa can particularly hinder ulcer healing and increase its surface area.
Our in vivo study shows that platelet rich plasma possibly inhibits growth of many bacterial species, including S. aureus and P. aeruginosa. However, based on a single study, it is difficult to determine whether this effect can be attributed to platelet rich plasma, microbial interactions, transfer of bacteria during wound dressing or other host factors. The use of PRP increased the number of microbial species in the heal ing wound. At the same time, the percentage of patients with cultureconfirmed P. aeruginosa after PRP therapy has risen, which can be attributed to ulcer colonisation with nosocomial hospital strains. Nevertheless, these ulcerations tended to heal better despite the increased number of different microbial species. This may indi cate colonisation rather than actual infection. Undoubt edly, the decreased colony count of most species was a beneficial effect likely to promote ulcer healing. This, however, requires further study.
In conclusion, local application of platelet rich plasma onto the surface of venous ulcers reduces the number of colonies, contributing to the increased vari ety of microbial flora at the same time.
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